RUNX1 and metabolic dysfunction-associated steatohepatitis: On the one hand, Kaur et al. explained that RUNX1 expression was significantly correlated with inflammation, fibrosis, and NASH activity score in NASH patients [16], which contrasts with the results in our cohort.